Through chemical screening, a promising drug named TT-10, acting on YAP1-TEAD1 activity and the Wnt/B-catenin signaling pathway, improved the cardiac function of mice after MI, acting on cell proliferation [108] (Figure 3a). Here, YAP1 is linked to myocardial infarction.